Sun Pharma Advanced Research Company Ltd
NSE :SPARC BSE :532872 Sector : PharmaceuticalsBuy, Sell or Hold SPARC? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
14 Nov 197.38 (-0.67%) | 13 Nov 198.71 (-3.24%) | 12 Nov 205.37 (-0.71%) | 11 Nov 206.84 (-0.29%) | 08 Nov 207.44 (-2.10%) | 07 Nov 211.88 (-1.28%) | 06 Nov 214.63 (2.28%) | 05 Nov 209.84 (2.30%) | 04 Nov 205.13 (-5.01%) | 01 Nov 215.94 (0.02%) | 31 Oct 215.90 (0.06%) | 30 Oct 215.78 (1.99%) | 29 Oct 211.58 (1.44%) | 28 Oct 208.58 (1.50%) | 25 Oct 205.49 (-1.10%) | 24 Oct 207.77 (-0.12%) | 23 Oct 208.02 (-0.02%) | 22 Oct 208.06 (-0.59%) | 21 Oct 209.29 (-2.92%) | 18 Oct 215.59 (2.65%) | 17 Oct 210.02 (-1.54%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Very Bearish
Moving Averages
5 DMA
Bearish
202.98
10 DMA
Bearish
207.27
20 DMA
Bearish
208.94
50 DMA
Bearish
213.76
100 DMA
Bearish
221.03
200 DMA
Bearish
265.15
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 14, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 209.71 | 205.48 | 199.66 | - | - |
R2 | 205.48 | 202.32 | 198.9 | 205.53 | - |
R1 | 201.43 | 200.36 | 198.14 | 201.53 | 203.46 |
P | 197.2 | 197.2 | 197.2 | 197.25 | 198.21 |
S1 | 193.15 | 194.04 | 196.62 | 193.25 | 195.18 |
S2 | 188.92 | 192.08 | 195.86 | 188.97 | - |
S3 | 184.87 | 188.92 | 195.1 | - | - |
Key Metrics
EPS
0
P/E
0
P/B
51.26
Dividend Yield
0%
Market Cap
6,405 Cr.
Face Value
1
Book Value
3.85
ROE
0%
EBITDA Growth
-103.87 Cr.
Debt/Equity
0.12
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Sun Pharma Advanced Research Company Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 29.67 | 20.25 | 20.96 | 18.37 | 12.9 |
PROFIT | -86.42 | -99.65 | -105.79 | -95.9 | -107.33 |
EPS | -2.66 | -3.07 | -3.26 | -2.96 | -3.31 |
Sun Pharma Advanced Research Company Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 29.67 | 20.25 | 20.96 | 18.37 | 12.9 |
PROFIT | -86.42 | -99.65 | -106.69 | -96.84 | -107.69 |
EPS | -2.66 | -3.07 | -3.29 | -2.98 | -3.32 |
Profit & Loss (Figures in Rs. Crores)
Sun Pharma Advanced Research Company Ltd Profit & Loss
Mar 2023 | Mar 2024 | ||
INCOME | 249.66 | 105.02 | |
PROFIT | -222.47 | -387.79 | |
EPS | -6.86 | -11.93 |
Sun Pharma Advanced Research Company Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 158.77 | 164.22 | 194.74 | 132.18 | 196.38 | 86.57 | 258.37 | 144.09 | 249.66 | 105.02 | |
PROFIT | -39.72 | -69.91 | -119.03 | -249.98 | -150.61 | -318.67 | -151.4 | -208.29 | -222.47 | -388.69 | |
EPS | 0 | 0 | 0 | 0 | 0 | -11.92 | -5.77 | -7.48 | -6.86 | -11.96 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | |
SOURCES OF FUNDS : | ||
Share Capital | 32.45 | 32.45 |
Reserves Total | 93.3 | 480.32 |
Total Shareholders Funds | 125.75 | 512.77 |
Secured Loans | 47 | 0.05 |
Unsecured Loans | 14.15 | 15.62 |
Total Debt | 61.15 | 15.67 |
Other Liabilities | 113.57 | 125.79 |
Total Liabilities | 300.47 | 654.23 |
APPLICATION OF FUNDS : | ||
Gross Block | 157.14 | 146.22 |
Less: Accumulated Depreciation | 49.6 | 40.47 |
Net Block | 107.54 | 105.75 |
Capital Work in Progress | 43.79 | 27 |
Investments | 1.8 | 290.9 |
Sundry Debtors | 15.53 | 32.71 |
Cash and Bank Balance | 155.33 | 111.58 |
Loans and Advances | 96.72 | 19.78 |
Total Current Assets | 267.58 | 164.07 |
Current Liabilities | 200.68 | 169.4 |
Provisions | 13.89 | 6.49 |
Total Current Liabilities & Provisions | 214.57 | 175.89 |
Net Current Assets | 53.01 | -11.83 |
Deferred Tax Assets | 29.42 | 27.9 |
Deferred Tax Liability | 28.15 | 27.9 |
Net Deferred Tax | 1.27 | 0 |
Other Assets | 93.07 | 242.41 |
Total Assets | 300.48 | 654.23 |
Contingent Liabilities | 197.21 | 197.21 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 32.45 | 32.45 | 27.19 | 26.21 | 26.21 | 26.21 | 25.09 | 24.69 | 23.67 | 23.67 |
Reserves Total | 92.4 | 480.32 | -230.22 | -194.46 | -44.84 | 270.03 | 159.63 | 133.47 | 6.23 | 76.13 |
Equity Share Warrants | 0 | 0 | 234.26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Application Money | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.9 | 0 |
Total Shareholders Funds | 124.85 | 512.77 | 31.23 | -168.25 | -18.63 | 296.24 | 184.72 | 158.16 | 31.8 | 99.8 |
Secured Loans | 47 | 0.05 | 75 | 150 | 5.83 | 0 | 0 | 0 | 1.28 | 0.4 |
Unsecured Loans | 9.23 | 15.62 | 4.21 | 86.38 | 61.09 | 1.64 | 2.28 | 3.14 | 54.47 | 3.82 |
Total Debt | 56.23 | 15.67 | 79.21 | 236.38 | 66.92 | 1.64 | 2.28 | 3.14 | 55.75 | 4.22 |
Other Liabilities | 110.38 | 125.79 | 74.99 | 47.87 | 49.47 | 6.11 | 6.34 | 4.18 | 3.3 | 2.45 |
Total Liabilities | 291.46 | 654.23 | 185.43 | 116 | 97.76 | 303.99 | 193.34 | 165.48 | 90.85 | 106.47 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 151.87 | 146.22 | 133.15 | 122.51 | 135.5 | 80.22 | 67.17 | 77.28 | 106.82 | 96.38 |
Less : Accumulated Depreciation | 49.22 | 40.47 | 41.28 | 31.95 | 31.64 | 22.66 | 15.44 | 8.12 | 36.86 | 29.58 |
Net Block | 102.65 | 105.75 | 91.87 | 90.56 | 103.86 | 57.56 | 51.73 | 69.16 | 69.96 | 66.8 |
Capital Work in Progress | 43.79 | 27 | 26.37 | 5.23 | 32.07 | 24.13 | 3.27 | 1.47 | 0.87 | 0.02 |
Investments | 2.22 | 290.9 | 11.66 | 6.43 | 8.49 | 210.58 | 107.57 | 9.65 | 0 | 0 |
Sundry Debtors | 15.53 | 32.71 | 27.74 | 17.58 | 16.05 | 10.17 | 17.56 | 38.9 | 9.16 | 19.89 |
Cash and Bank Balance | 155.06 | 111.58 | 1.23 | 9.31 | 0.46 | 0.68 | 1.32 | 70.31 | 12.75 | 17.34 |
Loans and Advances | 74.01 | 19.77 | 30.53 | 29.8 | 42.19 | 35.96 | 48.77 | 39.42 | 44.68 | 25.7 |
Total Current Assets | 244.61 | 164.06 | 59.49 | 56.69 | 58.7 | 46.81 | 67.66 | 148.63 | 66.59 | 62.93 |
Current Liabilities | 191.32 | 169.4 | 89.37 | 107.94 | 169.5 | 90.04 | 111.36 | 103.72 | 69.69 | 35.44 |
Provisions | 3.55 | 6.49 | 5.28 | 5.75 | 5.31 | 4.46 | 4.1 | 3.35 | 2.12 | 0.77 |
Total Current Liabilities & Provisions | 194.87 | 175.89 | 94.65 | 113.69 | 174.81 | 94.5 | 115.46 | 107.07 | 71.81 | 36.21 |
Net Current Assets | 49.74 | -11.83 | -35.16 | -57 | -116.11 | -47.69 | -47.8 | 41.56 | -5.22 | 26.73 |
Deferred Tax Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.53 | 21.89 | 20.62 |
Deferred Tax Liability | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23.53 | 21.89 | 20.62 |
Other Assets | 93.07 | 242.41 | 90.7 | 70.79 | 69.44 | 59.41 | 78.58 | 43.64 | 25.24 | 12.92 |
Total Assets | 291.47 | 654.23 | 185.43 | 116.01 | 97.75 | 303.98 | 193.35 | 165.48 | 90.85 | 106.47 |
Contingent Liabilities | 197.21 | 197.21 | 197.21 | 188.09 | 185.98 | 175.29 | 122.17 | 52.68 | 20.3 | 20.37 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | -386.83 |
Depreciation | 12.51 |
Interest (Net) | -23.77 |
P/L on Sales of Assets | -0.58 |
Prov. and W/O (Net) | 2.05 |
P/L in Forex | 2.06 |
Total Adjustments (PBT and Ext... | -10.91 |
Operating Profit before Workin... | -397.74 |
Trade and 0ther Receivables | 15.21 |
Trade Payables | -5.89 |
Total Adjustments (OP before W... | -27.33 |
Cash Generated from/(used in) ... | -425.08 |
Direct Taxes Paid | -4.11 |
Total Adjustments(Cash Generat... | -4.11 |
Cash Flow before Extraordinary... | -429.19 |
Net Cash from Operating Activi... | -429.19 |
Purchased of Fixed Assets | -26.51 |
Sale of Fixed Assets | 0.49 |
Sale of Investments | 284.19 |
Interest Received | 22.37 |
Net Cash used in Investing Act... | 391.53 |
Proceed from 0ther Long Term B... | 64.41 |
Of the Long Tem Borrowings | -17.46 |
Of Financial Liabilities | -2.94 |
Interest Paid | -1.6 |
Net Cash used in Financing Act... | 42.41 |
Net Profit before Tax and Extr... | -388.11 |
Depreciation | 12.13 |
Interest (Net) | -23.81 |
P/L on Sales of Assets | -0.58 |
P/L on Sales of Invest | -3.18 |
Prov. and W/O (Net) | 2.05 |
P/L in Forex | 2.07 |
Total Adjustments (PBT and Ext... | -11.33 |
Operating Profit before Workin... | -399.44 |
Trade and 0ther Receivables | 15.21 |
Trade Payables | 1.58 |
Total Adjustments (OP before W... | -25.88 |
Cash Generated from/(used in) ... | -425.32 |
Direct Taxes Paid | -4.11 |
Total Adjustments(Cash Generat... | -4.11 |
Cash Flow before Extraordinary... | -429.43 |
Net Cash from Operating Activi... | -429.43 |
Purchased of Fixed Assets | -26.51 |
Sale of Fixed Assets | 0.49 |
Sale of Investments | 284.19 |
Interest Received | 22.37 |
Acquisition of Companies | -0.42 |
Net Cash used in Investing Act... | 391.11 |
Proceed from 0ther Long Term B... | 64.41 |
Of the Long Tem Borrowings | -17.46 |
Of Financial Liabilities | -2.59 |
Interest Paid | -1.56 |
Net Cash used in Financing Act... | 42.8 |
Company Details
Registered Office |
|
Address | Sun Pharma Advanced Res Centre, Akota Road Akota |
City | Vadodara |
State | Gujarat |
Pin Code | 390020 |
Tel. No. | 91-265-2330815/2339257 |
Fax. No. | 91-265-2354897 |
secretarial@sparcmail.com | |
Internet | http://www.sparc.life |
Registrars |
|
Address | Sun Pharma Advanced Res Centre |
City | Vadodara |
State | Gujarat |
Pin Code | 390020 |
Tel. No. | 91-265-2330815/2339257 |
Fax. No. | 91-265-2354897 |
secretarial@sparcmail.com | |
Internet | http://www.sparc.life |
Management |
|
Name | Designation |
T Rajamannar | Non Executive Director |
Sudhir V Valia | Non Executive Director |
Bhavna Doshi | Independent Director |
Ferzaan Engineer | Independent Director |
Robert Spiegel | Independent Director |
Dilip S Shanghvi | Chairman (Non-Executive) |
Kajal Damania. | Company Sec. & Compli. Officer |
Vidhi Shanghvi | Non Executive Director |